ArticleBMC cardiovascular disorders2023
SGLT2 inhibitors can reduce the incidence of abnormal blood glucose caused by statins in non-diabetes patients with HFrEF after PCI.
Yulin Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.